Newer antiarrhythmic drugs.
D000284:Administration, Oral; D000328:Adult; D000638:Amiodarone / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001073:Aprindine / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000601:surgery; D002648:Child; D004491:Edrophonium / Q000627:therapeutic use; D004594:Electrophysiology; D006329:Heart Conduction System / Q000187:drug effects; D006352:Heart Ventricles; D006801:Humans; D007275:Injections, Intravenous; D008012:Lidocaine / Q000031:analogs & derivatives / Q000494:pharmacology; D008801:Mexiletine / Q000494:pharmacology; D012008:Recurrence; D013610:Tachycardia / Q000188:drug therapy; D016677:Tocainide; D014700:Verapamil / Q000627:therapeutic use; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D008801:Mexiletine; D016677:Tocainide; D001073:Aprindine; D004491:Edrophonium; D008012:Lidocaine; D014700:Verapamil; D000638:Amiodarone